Alain Brunet, PhD, studies risk factors and develops effective treatments for PTSD, such as early intervention and reconsolidation blockade.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

Christina Gianoulakis wants to elucidate the role of the endogenous opioid peptide systems in mediating the reinforcing effects of alcohol.

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Nicolas Cermakian is studying the molecular mechanisms underlying circadian rhythms, especially in animal models.

Thomas Brown studies the development of psychosocial interventions to combat substance abuse.

Serge Beaulieu studies neurobiological responses to antidepressant and mood stabilizer treatment in bipolar disorders.

Researchers examining the “Mood, Anxiety, and Impulsivity-related Disorders” theme are aiming to identify the genetic , psychological, neurobiological and environmental causes of most mood disorders and testing the most effective treatments. Their main focus is on: Depression Bipolar disorder Personality disorders Post-traumatic stress disorder Eating disorders Substance dependence, e.g. drug or alcohol Suicide Identifying risk factors and responding ef...

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...